What Is Segmental Vitiligo?
When white patches appear on the skin, the first instinct is to wonder — will this spread? Will it cross to the other side? For patients with segmental vitiligo, the answer is often no. That is what makes this type so distinct from every other form of the condition.
Segmental vitiligo (SV) is a type of vitiligo in which depigmented patches appear on one side of the body only, confined to a single segment or dermatomal region — meaning they follow the distribution of a nerve pathway in the skin. Once the initial spreading phase ends, the patches almost always stabilise and do not cross to the opposite side of the body.
This one-sided, nerve-aligned nature is what defines segmental vitiligo — and it is also what makes its biology, behaviour, and treatment fundamentally different from the more common non-segmental (generalised) vitiligo.
At Dr. Abdul Adal’s clinic in Hyderabad, we see patients with segmental vitiligo at all stages — from early-spreading disease in children to long-stabilised patches in adults seeking surgical repigmentation. Understanding this type in full is the first step toward effective care.
How Common Is Segmental Vitiligo?
Segmental vitiligo accounts for approximately 10–15% of all vitiligo cases worldwide. It is less common than non-segmental vitiligo, which makes up roughly 85–90% of presentations. However, segmental vitiligo is seen more frequently in children and adolescents — making it the most common subtype in paediatric vitiligo patients.
In India, where vitiligo affects a significant portion of the population in certain regions, segmental vitiligo is not rare. Families who notice one-sided white patches in a child or teenager should seek specialist evaluation early — the first months are clinically significant.
Segmental Vitiligo vs. Non-Segmental Vitiligo: Key Differences
Understanding why segmental vitiligo is different requires comparing it directly with the generalised form. These are not merely variations in pattern — they differ in their underlying biology, the way they progress, their associations with other conditions, and how they respond to treatment.
| Feature | Segmental Vitiligo (SV) | Non-Segmental Vitiligo (NSV) |
|---|---|---|
| Distribution | Unilateral — one side of the body only | Bilateral — both sides, symmetrically |
| Pattern | Follows a dermatome (nerve pathway) | Scattered or symmetrical |
| Prevalence | 10–15% of cases | 85–90% of cases |
| Age of onset | Often childhood or adolescence | Any age; common in adults |
| Progression | Rapid early spread, then stabilises | Unpredictable; may spread for years |
| Autoimmune link | Weaker — not strongly autoimmune | Strong — linked to thyroid, diabetes, alopecia |
| Koebner phenomenon | Rare | Yes — new patches at trauma sites |
| Response to systemic therapy | Limited | Moderate to good |
| Best treatment once stable | Surgical repigmentation | Phototherapy + topicals + JAK inhibitors |
The most important practical difference is this: non-segmental vitiligo is driven primarily by the immune system attacking melanocytes across the body, while segmental vitiligo is thought to involve a local neural mechanism — abnormal nerve signals in a specific skin segment that damage nearby melanocytes. This is why systemic immunosuppressants that work well for non-segmental vitiligo often have limited effect on segmental disease.
To read more about the generalised form and how it compares, see our detailed guide: Non-Segmental (Generalised) Vitiligo Explained.
What Causes Segmental Vitiligo?
The exact cause of segmental vitiligo is not yet fully established, but current scientific evidence points to a distinct biological mechanism that differs from the autoimmune pathway seen in non-segmental vitiligo.
The Neural (Nerve) Hypothesis
The leading theory for segmental vitiligo is the neural hypothesis. Because SV patches follow dermatomal distributions — the same zones of skin innervated by specific spinal nerve roots — researchers believe that abnormal neurochemical activity in those nerve pathways plays a central role.
According to this theory, affected nerves release toxic substances or neuropeptides that selectively damage melanocytes in the skin segment they supply. This would explain the strict one-sided, dermatomal pattern and why the condition tends to stabilise once the initial phase ends — unlike the ongoing, system-wide immune attack in non-segmental vitiligo.
The Somatic Mosaic Hypothesis
Another proposed mechanism is somatic mosaicism — the idea that a subset of skin cells in the affected segment carries a genetic mutation that makes the local melanocytes vulnerable to destruction. This mutation would be present only in that region, which would explain the strict localisation.
Autoimmune Involvement
While segmental vitiligo is far less closely linked to autoimmunity than the non-segmental type, some cases — particularly those in the mixed vitiligo category — do show overlap with immune dysregulation. The relationship between SV and the immune system is still an active area of research.
Triggers
As with other forms of vitiligo, certain events may trigger the onset or initial spread of segmental vitiligo in susceptible individuals:
- Skin trauma or injury in the affected segment
- Severe stress or psychological shock
- Viral illness or local infection
- Hormonal changes during puberty — one reason why SV frequently begins in adolescence
Where Does Segmental Vitiligo Appear?
Segmental vitiligo can affect any dermatomal region of the body. The most commonly involved areas include:
- Face — particularly along one side of the forehead, cheek, jaw, or around one eye. Facial involvement often follows the trigeminal nerve distribution.
- Neck and chest — one-sided patches following cervical or thoracic dermatomes
- Trunk — band-like patches on one side of the abdomen or back
- Arm or hand — patches confined to one limb or one side of a limb
- Leg or foot — following lumbosacral nerve distributions
- Scalp — often associated with white hair (leukotrichia) in the affected patch
A characteristic and diagnostically significant finding in segmental vitiligo is poliosis — the premature whitening of hair within the affected segment. This includes scalp hair, eyebrows, eyelashes, and beard hair growing from depigmented skin. Poliosis is particularly common in facial segmental vitiligo.
How Does Segmental Vitiligo Progress?
Understanding the natural history of segmental vitiligo is essential — both for setting patient expectations and for planning treatment at the right time.
Phase 1: Active Spreading (Weeks to Months)
When segmental vitiligo begins, it typically spreads rapidly within its segment. New patches may appear quickly, existing patches enlarge, and within a period of weeks to months, the full extent of the affected area becomes apparent. This early phase can be alarming for patients and families — particularly because the spread can seem fast and unpredictable.
Phase 2: Stabilisation (Usually Within 1–2 Years)
The defining characteristic of segmental vitiligo is that this early spread almost always stops. In the vast majority of patients, segmental vitiligo stabilises within 6 months to 2 years of onset, after which no new patches appear and existing patches remain static. Unlike non-segmental vitiligo, there is generally no lifelong unpredictable spreading.
Phase 3: Stable Disease
Once stable, segmental vitiligo patches remain unchanged for years or decades. Because the patches do not spread and are confined to one side of the body, stable segmental vitiligo is an excellent candidate for surgical repigmentation — the gold standard approach once the disease has declared its boundaries.
This progression pattern has important implications: patients who seek evaluation during the active phase can benefit from treatments to slow early spread, while those with long-stable disease are prime candidates for surgical intervention.
Recognising Segmental Vitiligo: Signs and Symptoms
Segmental vitiligo is primarily a visual condition. The key signs to recognise include:
White or milky-white patches — flat, well-demarcated depigmented patches that are completely devoid of melanin, smooth in texture, and confined to one side of the body.
One-sided (unilateral) distribution — patches appear only on one side. If you draw an imaginary line down the centre of the body, segmental vitiligo patches do not cross it.
Dermatomal pattern — the patches follow the distribution of a nerve, which means they tend to have a band-like, streak-like, or segment-specific arrangement rather than randomly scattered spots.
Poliosis — white or grey hair within the affected patch. This is common in facial and scalp segmental vitiligo and is often one of the first noticeable signs.
Rapid early onset — segmental vitiligo typically appears and spreads more quickly in its initial phase than non-segmental vitiligo.
No symptoms in the patch — like all forms of vitiligo, segmental vitiligo is asymptomatic. The patches are not itchy, painful, or physically uncomfortable (unless sunburned, since depigmented skin has no melanin protection).
Diagnosing Segmental Vitiligo
An accurate diagnosis of segmental vitiligo — and, critically, distinguishing it from non-segmental vitiligo — is essential for choosing the right treatment. At Dr. Abdul Adal’s clinic in Hyderabad, the diagnostic process for suspected segmental vitiligo includes:
Clinical Examination
A careful visual assessment of the pattern, distribution, and borders of the patches is the foundation of diagnosis. The unilateral, dermatomal distribution is the primary clinical indicator of segmental vitiligo. The specialist will also assess whether patches are actively spreading or stable.
Wood’s Lamp Examination
Under a Wood’s lamp (a UV blacklight), depigmented vitiligo patches glow with a distinctive blue-white fluorescence, making subtle early patches visible that might not be obvious in normal light — particularly in patients with lighter skin tones.
Dermoscopy
Magnified dermoscopic examination helps evaluate patch borders and perilesional skin, giving insights into disease activity. Active vitiligo shows characteristic changes at the edges; stable vitiligo tends to have sharper, well-defined borders.
Ruling Out Other Causes
Several other conditions can cause localised depigmentation — including pityriasis versicolor, post-inflammatory hypopigmentation, naevus depigmentosus, and lichen sclerosus. An experienced specialist differentiates segmental vitiligo from these through clinical assessment and, where needed, Wood’s lamp or biopsy.
Assessment for Associated Conditions
While segmental vitiligo has a weaker autoimmune association than the non-segmental type, baseline screening is still recommended. If there are features suggesting mixed vitiligo or overlap with non-segmental disease, thyroid function tests and blood glucose screening become particularly important. We follow our complete vitiligo diagnostic protocol for all patients presenting with white patches.
Treatment of Segmental Vitiligo
Treating segmental vitiligo requires a different approach than treating non-segmental vitiligo. Because the mechanism is largely neural rather than systemic autoimmune, and because the disease stabilises naturally, the treatment strategy is phase-dependent — what you do in the active phase is different from what is possible in the stable phase.
During the Active Phase: Slow the Spread
In the early, actively spreading phase of segmental vitiligo, the goal is to slow progression and limit the extent of the affected segment. Options include:
Topical corticosteroids are applied to patches to modulate local immune activity and potentially slow spreading. Potency is selected based on the body site and patient age. These are a practical, accessible first-line option.
Topical calcineurin inhibitors — tacrolimus or pimecrolimus ointment — are particularly valuable for facial involvement (where long-term steroid use is avoided) and in children. They have a strong safety profile and can reduce active spreading.
Mini-pulse oral corticosteroids — a low-dose, short-course oral steroid regimen (such as betamethasone on two days per week) can be used in selected patients with rapidly progressive segmental vitiligo to arrest early spreading. This approach requires careful specialist supervision.
Narrowband UVB phototherapy can also play a role in the active phase, helping to modulate local immune activity and stimulate any remaining melanocytes. It is particularly useful when patches are actively spreading or when topical therapy alone is insufficient.
The latest vitiligo treatments — including topical JAK inhibitors like ruxolitinib cream — are also being studied and used in segmental cases, particularly when there is evidence of localised immune activity. Discuss current options with your specialist.
During the Stable Phase: Repigmentation
Once segmental vitiligo has been stable for at least 12–24 months — meaning no new patches have appeared and existing patches have not grown — the door opens to surgical repigmentation, which is the most effective long-term treatment for stable segmental vitiligo.
Why does stability matter? Surgical techniques transplant melanocytes (pigment cells) from healthy donor skin into the depigmented patches. For this to work, the disease must not be spreading — otherwise transplanted cells may be lost to the same process that caused the original depigmentation.
Surgical Options for Stable Segmental Vitiligo
Melanocyte-Keratinocyte Transplantation Procedure (MKTP) This is the most advanced and versatile surgical option. Melanocytes and keratinocytes are harvested from a small area of normal donor skin, processed into a cell suspension in a laboratory, and applied to the prepared recipient (depigmented) areas. MKTP can cover large surface areas in a single session and produces excellent, natural-looking repigmentation with minimal donor site scarring. Success rates for segmental vitiligo are consistently high — typically 60–90% repigmentation in well-selected cases.
Suction Blister Grafting A vacuum device creates a controlled blister on normal pigmented skin. The blister roof, which is rich in melanocytes, is harvested and transplanted to a prepared vitiligo patch. This technique is particularly effective for smaller segmental patches and produces very natural colour matching with minimal trauma.
Punch Grafting Small plugs of normal skin are transplanted to the depigmented patch at regular intervals. A simpler technique but limited to smaller areas; colour matching can occasionally be inconsistent.
Split-Thickness Skin Grafting A thin layer of normal skin is grafted to a larger depigmented area. Effective but more invasive, with visible donor site changes. Used selectively for larger patches where other techniques are impractical.
Follicular Unit Extraction (FUE) for Hair-Bearing Areas For segmental vitiligo affecting the scalp or beard, hair follicle grafts containing melanocytes can be transplanted into the depigmented area. Particularly valuable when poliosis (white hair) accompanies the white patches — the procedure can restore both skin and hair pigmentation.
Phototherapy After Surgery
Surgical repigmentation is often combined with post-operative narrowband UVB phototherapy or excimer laser sessions. Light therapy helps stimulate the transplanted melanocytes to proliferate and spread, expanding the area of repigmentation beyond the immediate graft site and improving the uniformity of colour matching.
Excimer Laser for Localised Segmental Patches
For smaller, well-defined stable patches — particularly on the face, scalp, or hands — the 308 nm excimer laser offers targeted, high-intensity UVB delivery precisely to the depigmented area. It spares surrounding normal skin and can produce visible repigmentation within weeks of treatment in suitable patients. It is particularly useful when surgery is not yet indicated or desired.
What About JAK Inhibitors?
JAK inhibitors — including topical ruxolitinib cream and oral agents like tofacitinib — have revolutionised the treatment of non-segmental vitiligo by targeting the immune pathway that drives melanocyte destruction. In segmental vitiligo, their role is more limited, given that the underlying mechanism is thought to be neural rather than primarily immune-driven. However, in mixed cases or where there is evidence of local immune involvement, JAK inhibitor therapy may be considered. Speak with your specialist about whether this is appropriate for your specific case.
For a full overview of the latest treatment advances across all vitiligo types, see: Latest Vitiligo Treatments That Actually Work in 2026.
Treatment Response: What Results Can You Expect?
Segmental vitiligo has a different — and often more favourable — response to surgical treatment than non-segmental vitiligo. Here is a realistic picture of what to expect:
| Treatment | Best Suited For | Expected Results |
|---|---|---|
| Topical corticosteroids / calcineurin inhibitors | Active phase, limited patches | Slows spread; partial repigmentation possible |
| NB-UVB phototherapy | Active or early stable phase | Moderate repigmentation; better in combination |
| Excimer laser | Stable, localised patches | Visible improvement within weeks to months |
| Suction blister grafting | Small to medium stable patches | 70–90% repigmentation |
| MKTP (cell transplant) | Large or multiple stable patches | 60–90% repigmentation |
| Punch grafting | Small stable patches | Good but variable colour matching |
| FUE for scalp/beard | Stable hair-bearing area patches | Repigments skin and hair |
The key message is that stable segmental vitiligo is one of the most treatable forms of vitiligo, and patients who have waited years living with one-sided patches may be excellent candidates for surgical repigmentation with very satisfying results.
Segmental Vitiligo in Children: Special Considerations
Because segmental vitiligo frequently begins in childhood or early adolescence, it deserves particular attention in younger patients. Parents who notice rapidly spreading one-sided white patches in their child — especially on the face, scalp, or neck — should seek specialist evaluation promptly.
Early intervention in the active phase can help limit the final extent of the affected segment. Treatment options for children include topical calcineurin inhibitors (preferred over long-term steroids for children), supervised NB-UVB phototherapy, and in some cases mini-pulse oral corticosteroids under careful monitoring.
The psychological impact on children and adolescents should not be underestimated. Visible segmental vitiligo — particularly on the face — can affect a child’s confidence, social integration, and school experience. At Dr. Abdul Adal’s clinic, we work with families to ensure children receive age-appropriate education, emotional support, and a realistic, compassionate treatment plan.
Once the disease stabilises and the child is older, surgical repigmentation can be considered. Many adolescents and young adults achieve excellent cosmetic outcomes from MKTP or suction blister grafting, with long-lasting results.
Living with Segmental Vitiligo
Segmental vitiligo, by its nature, is confined to one part of the body — which means it does not carry the same anxiety of unpredictable, widespread spreading that accompanies non-segmental vitiligo. Yet the condition can still significantly affect quality of life, especially when patches are on the face, scalp, or hands.
Practical daily care for segmental vitiligo includes:
- Daily sunscreen (SPF 30+) on all depigmented patches. Without melanin, these areas burn easily and are more vulnerable to UV damage.
- Protective clothing over affected areas during prolonged sun exposure.
- Medical camouflage — dermatologist-tested, waterproof concealers and tinted sunscreens can help patients manage visible patches, particularly on the face, while undergoing treatment or awaiting surgery.
- Avoiding unnecessary skin trauma in the affected segment, particularly during the active spreading phase.
- Regular follow-up with your vitiligo specialist to monitor stability and time surgical intervention appropriately.
The emotional aspect of living with a visible skin condition deserves acknowledgment. Vitiligo is not contagious. It is not caused by poor hygiene or diet. It is not a sign of illness in any other system of the body. These facts matter — particularly in communities where skin conditions carry unwarranted stigma.
If you are navigating the psychological dimensions of a vitiligo diagnosis, you are not alone. Many patients across Hyderabad and Telangana manage segmental vitiligo with medical care, cosmetic support, and the reassurance that comes from knowing their condition has a clear boundary and a real treatment pathway.
Frequently Asked Questions About Segmental Vitiligo
Q: Is segmental vitiligo the same as regular vitiligo? Segmental vitiligo is a distinct subtype of vitiligo. It appears on one side of the body, follows nerve pathways, stabilises early, and has a different underlying mechanism and treatment approach compared to non-segmental (generalised) vitiligo. Read our comprehensive vitiligo guide for an overview of all types.
Q: Will segmental vitiligo spread to the other side of my body? In almost all cases, no. The defining characteristic of segmental vitiligo is that it stays on one side of the body. Once it stabilises — usually within 6 months to 2 years of onset — it does not cross to the opposite side. This is one of the key differences from non-segmental vitiligo.
Q: Can segmental vitiligo be cured? There is no “cure” in the absolute sense, but stable segmental vitiligo can achieve excellent repigmentation through surgical techniques. Success rates of 60–90% repigmentation are realistic in well-selected patients. Early treatment in the active phase can also limit the extent of the condition.
Q: How do I know if my vitiligo has stabilised? Stability is generally defined as no new patches and no measurable growth of existing patches over a period of at least 12 months, ideally 24 months. Your specialist will assess this through serial clinical photographs and examination. Do not attempt to self-assess stability — consult a specialist.
Q: Is surgery painful for vitiligo treatment? Surgical repigmentation procedures like MKTP and suction blister grafting are performed under local anaesthesia. The procedures themselves are not painful, though some mild discomfort at the donor site is normal during the healing period. Most patients return to daily activities within a few days.
Q: My child has been diagnosed with segmental vitiligo. What should I do first? Seek evaluation at a specialist clinic with experience in paediatric vitiligo. Early treatment can help limit spreading during the active phase. Most importantly, avoid delay — the active phase is finite, and early intervention matters. Contact Dr. Abdul Adal’s clinic in Hyderabad for an appointment.
Q: Is segmental vitiligo associated with thyroid disease? The autoimmune link is much weaker in segmental vitiligo than in the non-segmental type. However, screening for thyroid disease is still performed at our clinic for all vitiligo patients, as a baseline and because some patients present with mixed vitiligo features.
Q: What is the best treatment for facial segmental vitiligo? For active facial segmental vitiligo, topical calcineurin inhibitors and excimer laser are first-line options. For stable facial segmental vitiligo, surgical approaches — particularly MKTP or suction blister grafting — produce excellent cosmetic results with natural colour matching.
Consult Dr. Abdul Adal — Vitiligo Specialist in Hyderabad
Segmental vitiligo requires a specialist who understands its distinct biology, recognises the critical treatment windows, and has the surgical expertise to deliver repigmentation when the time is right.
Dr. Abdul Adal has been treating all forms of vitiligo — including segmental vitiligo in children and adults — since 1986. With over 40 years of clinical experience, access to advanced diagnostic tools, and surgical repigmentation capabilities, the clinic offers comprehensive, personalised care for every presentation of this condition.
Whether you are in the early spreading phase or have lived with stable segmental vitiligo for years and are now ready to explore surgical options, Dr. Abdul Adal’s clinic in Banjara Hills, Hyderabad is here to help.
📞 Call: +91 81253 74380 💬 WhatsApp: Book an Appointment 🌐 Visit: psoriasisandvitiligospecialist.com 📍 Address: 8-2-277/G5, Flat No. 789, Road No. 2, Banjara Hills, Hyderabad
Clinic Hours: Monday – Sunday, 10:00 AM – 8:00 PM
